{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:12:13Z","timestamp":1795173133548,"version":"4.10.3"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/fpc.0000000000000150","type":"journal-article","created":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T16:19:49Z","timestamp":1433693989000},"page":"416-426","source":"Crossref","is-referenced-by-count":366,"title":["PharmGKB summary"],"prefix":"10.1097","volume":"25","author":[{"given":"Liudmila L.","family":"Mazaleuskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Sangkuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline F.","family":"Thorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garret A.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ B.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri E.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210213","first-page":"617","article-title":"What do we (not) know about how paracetamol (acetaminophen) works J Clin Pharm T","volume":"35","author":"Toussaint","year":"2010","journal-title":"her"},{"key":"R2-7-20210213","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"issue":"Suppl 1","key":"R4-7-20210213","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1002\/phar.1511","article-title":"Postmarketing review of intravenous acetaminophen dosing based on Food and Drug Administration prescribing guidelines.","volume":"34","author":"dela Cruz Ubaldo","year":"2014","journal-title":"Pharmacotherapy"},{"key":"R5-7-20210213","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccc.2012.07.006","article-title":"A review of acetaminophen poisoning.","volume":"28","author":"Hodgman","year":"2012","journal-title":"Crit Care Clin"},{"key":"R6-7-20210213","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2146\/news110069","article-title":"Spell out acetaminophen for patients sake, group says.","volume":"68","author":"Thompson","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"R7-7-20210213","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jama.2014.716","article-title":"FDA asks physicians to stop prescribing high-dose acetaminophen products.","volume":"311","author":"Mitka","year":"2014","journal-title":"JAMA"},{"key":"R8-7-20210213","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm Res"},{"key":"R9-7-20210213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/20014091111677","article-title":"Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches.","volume":"31","author":"Bessems","year":"2001","journal-title":"Crit Rev Toxicol"},{"key":"R10-7-20210213","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2165\/00003495-198325030-00002","article-title":"Paracetamol overdosage. Pharmacological considerations and clinical management.","volume":"25","author":"Prescott","year":"1983","journal-title":"Drugs"},{"key":"R11-7-20210213","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","article-title":"Acetaminophen-induced hepatotoxicity.","volume":"31","author":"James","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"R13-7-20210213","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985).","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J Med"},{"key":"R14-7-20210213","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1476-5381.1973.tb08536.x","article-title":"The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study.","volume":"49","author":"Prescott","year":"1973","journal-title":"Br J Pharmacol"},{"key":"R15-7-20210213","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/0006-2952(93)90437-2","article-title":". Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases.","volume":"45","author":"Bock","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"R16-7-20210213","first-page":"998","article-title":"Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.","volume":"299","author":"Court","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-7-20210213","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/tx050317i","article-title":"Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.","volume":"19","author":"Mutlib","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"R18-7-20210213","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/toxsci\/kfi211","article-title":". Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes.","volume":"87","author":"Kostrubsky","year":"2005","journal-title":"Toxicol Sci"},{"key":"R19-7-20210213","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/03602532.2010.527984","article-title":"Paracetamol metabolism and related genetic differences.","volume":"43","author":"Zhao","year":"2011","journal-title":"Drug Metab Rev"},{"key":"R20-7-20210213","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.112.202010","article-title":". Acute Liver Failure Study Group. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042Cgt;G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.","volume":"345","author":"Court","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-7-20210213","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1124\/jpet.104.081968","article-title":"UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S).","volume":"313","author":"Krishnaswamy","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-7-20210213","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1442-200X.2012.03602.x","article-title":". Acetaminophen administration in a patient with Gilberts syndrome.","volume":"54","author":"Nakagawa","year":"2012","journal-title":"Pediatr Int"},{"key":"R23-7-20210213","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000097908","article-title":"Effects of combined UDP-glucuronosyltransferase (UGT) 1A128 and 1A62 on paracetamol pharmacokinetics in beta-thalassemiaHbE.","volume":"79","author":"Tankanitlert","year":"2007","journal-title":"Pharmacology"},{"key":"R24-7-20210213","first-page":"323","article-title":"Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity.","volume":"247","author":"De Morais","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R25-7-20210213","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0016-5085(92)90106-9","article-title":"Decreased glucuronidation and increased bioactivation of acetaminophen in Gilberts syndrome.","volume":"102","author":"De Morais","year":"1992","journal-title":"Gastroenterology"},{"key":"R26-7-20210213","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1124\/dmd.111.039149","article-title":". UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables.","volume":"39","author":"Navarro","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"R27-7-20210213","first-page":"43","article-title":"Acetaminophen and phenol: substrates for both a thermostable and a thermolabile form of human platelet phenol sulfotransferase.","volume":"221","author":"Reiter","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"R28-7-20210213","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.tpj.6500223","article-title":"Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes.","volume":"4","author":"Freimuth","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"R29-7-20210213","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bdra.20535","article-title":"Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects.","volume":"82","author":"Adjei","year":"2008","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R30-7-20210213","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0003-9861(89)90278-6","article-title":"Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2.","volume":"271","author":"Raucy","year":"1989","journal-title":"Arch Biochem Biophys"},{"key":"R31-7-20210213","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/tx9701687","article-title":"Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6.","volume":"11","author":"Chen","year":"1998","journal-title":"Chem Res Toxicol"},{"key":"R32-7-20210213","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1006\/bbrc.2002.6541","article-title":"Reduction of toxic metabolite formation of acetaminophen.","volume":"291","author":"Hazai","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-7-20210213","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1067\/mcp.2000.104736","article-title":"Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation.","volume":"67","author":"Manyike","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"R34-7-20210213","first-page":"1397","article-title":"Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen.","volume":"28","author":"Dong","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"R35-7-20210213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/00498250802512830","article-title":"Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes.","volume":"39","author":"Laine","year":"2009","journal-title":"Xenobiotica"},{"key":"R36-7-20210213","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/0006-2952(93)90295-8","article-title":"Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4.","volume":"45","author":"Thummel","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"R37-7-20210213","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/tx00034a019","article-title":"Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics.","volume":"6","author":"Patten","year":"1993","journal-title":"Chem Res Toxicol"},{"key":"R38-7-20210213","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0021-9258(19)75736-6","article-title":"The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase.","volume":"262","author":"Potter","year":"1987","journal-title":"J Biol Chem"},{"key":"R39-7-20210213","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-291X(80)91238-3","article-title":"Metabolism of paracetamol to a glutathione conjugate catalyzed by prostaglandin synthetase.","volume":"96","author":"Moldeus","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"R40-7-20210213","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-199631030-00005","article-title":"Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.","volume":"31","author":"Pirmohamed","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"R41-7-20210213","doi-asserted-by":"crossref","first-page":"d2218","DOI":"10.1136\/bmj.d2218","article-title":"Management of paracetamol poisoning.","volume":"342","author":"Ferner","year":"2011","journal-title":"BMJ"},{"key":"R42-7-20210213","first-page":"341","article-title":"Acetaminophen safety and hepatotoxicity - where do we go from here Expert Opin Drug S","volume":"6","author":"Amar","year":"2007","journal-title":"af"},{"key":"R43-7-20210213","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","article-title":"Association of acetaminophen hepatotoxicity with fasting and ethanol use.","volume":"272","author":"Whitcomb","year":"1994","journal-title":"JAMA"},{"key":"R44-7-20210213","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2796.1992.tb00976.x","article-title":"Hepatotoxicity due to repeated intake of low doses of paracetamol.","volume":"231","author":"Eriksson","year":"1992","journal-title":"J Intern Med"},{"key":"R45-7-20210213","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0003-9861(88)90592-9","article-title":"The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study.","volume":"264","author":"Coles","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"R46-7-20210213","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.bbagen.2012.11.019","article-title":"Glutathione transferases, regulators of cellular metabolism and physiology.","volume":"1830","author":"Board","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"R47-7-20210213","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/096032719000900311","article-title":"Intravenous N-acetylcysteine, hepatotoxicity and plasma glutathione S-transferase in patients with paracetamol overdosage.","volume":"9","author":"Beckett","year":"1990","journal-title":"Hum Exp Toxicol"},{"key":"R48-7-20210213","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/gut.26.1.26","article-title":"Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatocellular damage.","volume":"26","author":"Beckett","year":"1985","journal-title":"Gut"},{"key":"R49-7-20210213","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":". Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system.","volume":"280","author":"Hogestatt","year":"2005","journal-title":"J Biol Chem"},{"key":"R50-7-20210213","first-page":"340","article-title":"Formation and disposition of the minor metabolites of acetaminophen in the hamster.","volume":"9","author":"Gemborys","year":"1981","journal-title":"Drug Metab Dispos"},{"key":"R51-7-20210213","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ki.1983.221","article-title":"Early functional and morphological changes in renal tubular necrosis due to p-aminophenol.","volume":"24","author":"Davis","year":"1983","journal-title":"Kidney Int"},{"key":"R52-7-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfj034","article-title":"The TRPV1 receptor: target of toxicants and therapeutics.","volume":"89","author":"Veronesi","year":"2006","journal-title":"Toxicol Sci"},{"key":"R53-7-20210213","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1124\/dmd.107.016170","article-title":". Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases.","volume":"35","author":"Barnes","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"R54-7-20210213","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejps.2012.02.016","article-title":". Impact of probe compound in MRP2 vesicular transport assays.","volume":"46","author":"Kidron","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"R55-7-20210213","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/dmd.110.037622","article-title":"Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.","volume":"39","author":"Kindla","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"R56-7-20210213","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2008.08.023","article-title":"Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells.","volume":"596","author":"Maeda","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R57-7-20210213","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R58-7-20210213","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00424-006-0054-9","article-title":"Multidrug resistance-associated proteins 3, 4, and 5.","volume":"453","author":"Borst","year":"2007","journal-title":"Pflugers Arch"},{"key":"R59-7-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0300-483X(79)90038-6","article-title":"Studies on the mechanism of paracetamol-induced protection against paracetamol hepatotoxicity.","volume":"12","author":"Strubelt","year":"1979","journal-title":"Toxicology"},{"key":"R60-7-20210213","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/toxsci\/kfu124","article-title":"Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.","volume":"141","author":"Rudraiah","year":"2014","journal-title":"Toxicol Sci"},{"key":"R61-7-20210213","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.510290241","article-title":"Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury.","volume":"29","author":"Shayiq","year":"1999","journal-title":"Hepatology"},{"key":"R62-7-20210213","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/096032719501400102","article-title":"Metabolic basis for high paracetamol dosage without hepatic injury: a case study.","volume":"14","author":"Tredger","year":"1995","journal-title":"Hum Exp Toxicol"},{"key":"R63-7-20210213","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.102.037580","article-title":". Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs.","volume":"303","author":"Khamdang","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R64-7-20210213","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-104-3-399","article-title":"Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure.","volume":"104","author":"Seeff","year":"1986","journal-title":"Ann Intern Med"},{"key":"R65-7-20210213","first-page":"590","article-title":"Acetaminophen hepatotoxicity: potentiation by isoniazid.","volume":"88","author":"Crippin","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"R66-7-20210213","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2125.1991.tb05501.x","article-title":"Inhibition of the metabolism of paracetamol by isoniazid.","volume":"31","author":"Epstein","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"R67-7-20210213","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s10620-006-9153-x","article-title":"Phenytoin-potentiated hepatotoxicity following acetaminophen overdose A closer look.","volume":"52","author":"Cook","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R68-7-20210213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/096032718800700106","article-title":"Fatal paracetamol poisoning in an epileptic.","volume":"7","author":"Minton","year":"1988","journal-title":"Hum Toxicol"},{"key":"R69-7-20210213","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2125.1979.tb00922.x","article-title":"Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.","volume":"7","author":"Perucca","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"R70-7-20210213","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/096032719201100405","article-title":"Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure.","volume":"11","author":"Bray","year":"1992","journal-title":"Hum Exp Toxicol"},{"key":"R71-7-20210213","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7326\/0003-4819-101-3-403_1","article-title":"Apparent potentiation of hepatotoxicity from small doses of acetaminophen by phenobarbital.","volume":"101","author":"Pirotte","year":"1984","journal-title":"Ann Intern Med"},{"key":"R72-7-20210213","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2125.1981.tb01193.x","article-title":"Effects of microsomal enzyme induction on paracetamol metabolism in man.","volume":"12","author":"Prescott","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"R73-7-20210213","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002280050132","article-title":"Selective liver enzyme induction by carbamazepine and phenytoin in Chinese epileptics.","volume":"50","author":"Tomlinson","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"R74-7-20210213","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.1993.125","article-title":"Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans.","volume":"54","author":"Zand","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R75-7-20210213","first-page":"311","article-title":"Perivenous expression of ethanol-inducible cytochrome P450 IIE1 in livers from alcoholics and chronically ethanol-fed rats.","volume":"1","author":"Buhler","year":"1991","journal-title":"Alcohol Alcohol Suppl"},{"key":"R76-7-20210213","doi-asserted-by":"crossref","first-page":"799","DOI":"10.7326\/0003-4819-113-10-799","article-title":"Severe acetaminophen toxicity in a patient receiving isoniazid.","volume":"113","author":"Murphy","year":"1990","journal-title":"Ann Intern Med"},{"key":"R77-7-20210213","doi-asserted-by":"crossref","first-page":"269","DOI":"10.36076\/ppj.2009\/12\/269","article-title":"Potential analgesic mechanisms of acetaminophen.","volume":"12","author":"Smith","year":"2009","journal-title":"Pain Physician"},{"issue":"Suppl","key":"R78-7-20210213","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease.","volume":"50","author":"Smyth","year":"2009","journal-title":"J Lipid Res"},{"key":"R79-7-20210213","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1160\/TH06-08-0444","article-title":"The pharmacology of selective inhibition of COX-2.","volume":"96","author":"Grosser","year":"2006","journal-title":"Thromb Haemost"},{"key":"R80-7-20210213","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1073\/pnas.102588199","article-title":"Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.","volume":"99","author":"Boutaud","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R81-7-20210213","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clpt.2005.09.009","article-title":"New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases.","volume":"79","author":"Aronoff","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R82-7-20210213","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":". Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"R83-7-20210213","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/clpt.2013.166","article-title":"Metabolomics: integration of a new omics with clinical pharmacology.","volume":"94","author":"James","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"R84-7-20210213","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/clpt.2013.217","article-title":"Pharmacometabolomics Research Network. Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.","volume":"95","author":"Kaddurah-Daouk","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"R85-7-20210213","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1038\/psp.2014.6","article-title":"Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression.","volume":"3","author":"Jayachandran","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R86-7-20210213","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nature04648","article-title":". Pharmaco-metabonomic phenotyping and personalized drug treatment.","volume":"440","author":"Clayton","year":"2006","journal-title":"Nature"},{"key":"R87-7-20210213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2009.240","article-title":"Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans.","volume":"88","author":"Winnike","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R88-7-20210213","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1073\/pnas.0904489106","article-title":"Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.","volume":"106","author":"Clayton","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R89-7-20210213","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.104.002402","article-title":"The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity.","volume":"33","author":"Cheung","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"R91-7-20210213","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/15563650.2011.639713","article-title":". The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patients.","volume":"50","author":"Buchard","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"R92-7-20210213","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1124\/mol.105.019240","article-title":"Sulfotransferase (SULT) 1A1 polymorphic variants 1, 2, and 3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation.","volume":"69","author":"Nagar","year":"2006","journal-title":"Mol Pharmacol"},{"key":"R93-7-20210213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5414\/CPP42073","article-title":"Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype.","volume":"42","author":"Rauchschwalbe","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R94-7-20210213","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":". The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilberts syndrome.","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"R95-7-20210213","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","article-title":"Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism Proc Natl Acad Sci","volume":"95","author":"Beutler","year":"1998","journal-title":"USA"},{"key":"R96-7-20210213","first-page":"257","article-title":"Gilberts disease: a risk factor for paracetamol overdosage J H","volume":"18","author":"Esteban","year":"1993","journal-title":"epatol"},{"key":"R97-7-20210213","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","article-title":"Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilberts syndrome.","volume":"347","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"R98-7-20210213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-8278(02)00306-9","article-title":"Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilberts syndrome.","volume":"38","author":"Peters","year":"2003","journal-title":"J Hepatol"},{"key":"R99-7-20210213","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2362.1987.tb01242.x","article-title":"Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilberts syndrome.","volume":"17","author":"Ullrich","year":"1987","journal-title":"Eur J Clin Invest"},{"key":"R100-7-20210213","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1124\/dmd.113.053546","article-title":"Acute Liver Failure Study Group. Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.","volume":"42","author":"Court","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"R101-7-20210213","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2010.08.047","article-title":"Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma.","volume":"126","author":"Shaheen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R102-7-20210213","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thx.2009.121459","article-title":". Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort.","volume":"65","author":"Perzanowski","year":"2010","journal-title":"Thorax"},{"key":"R103-7-20210213","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1081-1206(10)60492-9","article-title":". Prenatal exposure to acetaminophen and respiratory symptoms in the first year of life.","volume":"101","author":"Persky","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R104-7-20210213","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ije\/dyn070","article-title":"Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study.","volume":"37","author":"Rebordosa","year":"2008","journal-title":"Int J Epidemiol"},{"key":"R105-7-20210213","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/thorax.57.11.958","article-title":"ALSPAC Study Team. Paracetamol use in pregnancy and wheezing in early childhood.","volume":"57","author":"Shaheen","year":"2002","journal-title":"Thorax"},{"key":"R106-7-20210213","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1101\/gr.090241.108","article-title":". Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.","volume":"19","author":"Harrill","year":"2009","journal-title":"Genome Res"},{"key":"R107-7-20210213","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1541-7786.MCR-11-0156","article-title":"Understanding the dual nature of CD44 in breast cancer progression.","volume":"9","author":"Louderbough","year":"2011","journal-title":"Mol Cancer Res"},{"key":"R108-7-20210213","first-page":"293","article-title":"CD44 - a new cardiovascular drug target or merely an innocent bystander Cardiovasc Hematol Disord Drug T","volume":"9","author":"Krettek","year":"2009","journal-title":"argets"},{"key":"R109-7-20210213","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2710.2004.00626.x","article-title":"Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects.","volume":"30","author":"Critchley","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"R110-7-20210213","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02280759","article-title":"Paracetamol elimination in Chinese and Indians in Singapore.","volume":"43","author":"Lee","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"R111-7-20210213","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/096032718500400404","article-title":"Paracetamol metabolism in African villagers.","volume":"4","author":"Sommers","year":"1985","journal-title":"Hum Toxicol"},{"key":"R112-7-20210213","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2125.1986.tb02953.x","article-title":"Inter-subject and ethnic differences in paracetamol metabolism.","volume":"22","author":"Critchley","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"R113-7-20210213","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2050-6511-13-8","article-title":"Low rates of hepatotoxicity among Asian patients with paracetamol overdose: a review of 1024 cases.","volume":"13","author":"Marzilawati","year":"2012","journal-title":"BMC Pharmacol Toxicol"},{"key":"R114-7-20210213","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0378-5173(01)00712-8","article-title":"Pharmacokinetics of acetaminophen in Hong Kong Chinese subjects.","volume":"222","author":"Yin","year":"2001","journal-title":"Int J Pharm"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T15:59:18Z","timestamp":1652284758000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201508000-00007"}},"subtitle":["pathways of acetaminophen metabolism at the therapeutic versus toxic doses"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000150","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}